The current PPH market cap is 497.04M. The company's latest EPS is USD 17.1336 and P/E is 5.38.
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.38M | ||||
Operating Income | 0 | ||||
Net Income | 2.12M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.3M | 4.21M | 5.62M | 8.92M | 10.39M |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | -25.57M | 28.27M | 41.02M | -57.82M | 92.32M |
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 262.54M | ||||
Total Liabilities | 1.24M | ||||
Total Equity | 261.29M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 150.04M | 237.56M | 340M | 580.24M | 448.42M |
Total Liabilities | 8.38M | 2.41M | 21.06M | 56.5M | 18.37M |
Total Equity | 141.66M | 235.15M | 318.94M | 523.74M | 430.05M |
Market Cap | 497.04M |
Price to Earnings Ratio | 5.38 |
Price to Sales Ratio | 47.82 |
Price to Cash Ratio | 1.86k |
Price to Book Ratio | 1.16 |
Dividend Yield | - |
Shares Outstanding | 5.39M |
Average Volume (1 week) | 212.78k |
Average Volume (1 Month) | 128.85k |
52 Week Change | 19.99% |
52 Week High | 92.53 |
52 Week Low | 74.05 |
Spread (Intraday) | 3.92 (4.18%) |
Company Name | VanEck Pharmaceuticals ETF |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.vaneck.com |
Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.